European Nuclear Medicine Guide
[1] Mattsson S, Johansson L, Leide Svegborn S, Liniecki J, Noßke D, Riklund KÅ, et al. ICRP Publication 128: Radiation Dose to Patients from Radiopharmaceuticals: a Compendium of Current Information Related to Frequently Used Substances. Ann ICRP 2015;44:7–321. https://doi.org/10.1177/0146645314558019
[2] Parker JA, Coleman RE, Grady E, Royal HD, Siegel BA, Stabin MG, et al. SNM practice guideline for lung scintigraphy 4.0. J Nucl Med Technol 2012;40:57–65. https://doi.org/10.2967/jnmt.111.101386.
[3] Milanesi O, Stellin G, Zucchetta P. Nuclear Medicine in Pediatric Cardiology. Semin Nucl Med 2017;47:158–69. https://doi.org/10.1053/j.semnuclmed.2016.10.008.
[4] Mortensen J, Gutte H. SPECT/CT and pulmonary embolism. European Journal of Nuclear Medicine and Molecular Imaging 2014;41 Suppl 1:S81–90. https://doi.org/10.1007/s00259-013-2614-5.
[5] Mortensen J, Berg RMG. Lung Scintigraphy in COPD. Seminars in Nuclear Medicine. 2019; 49(1): 16-21. https://doi.org/10.1053/j.semnuclmed.2018.10.010
[6] de Nijs R, Sijtsema ND, Kruis MF, Jensen CV, Iversen M, Perch M, Mortensen J. Comparison of 81mKrypton and 99mTc-Technegas for ventilation single-photon emission computed tomography in severe chronic obstructive pulmonary disease. Nucl Med Commun. 2021 Feb 1;42(2):160-168. doi: 10.1097/MNM.0000000000001314.
[7] Ciofetta G, Piepsz A, Roca I, Fisher S, Hahn K, Sixt R, et al. Guidelines for lung scintigraphy in children. Eur J Nucl Med Mol Imaging 2007;34:1518–26. https://doi.org/10.1007/s00259-007-0485-3
[8] Mortensen J, Gutte H. SPECT/CT and pulmonary embolism. European Journal of Nuclear Medicine and Molecular Imaging 2014;41 Suppl 1:S81–90. https://doi.org/10.1007/s00259-013-2614-5.
[9] ICRP. ICRP Publication 53. Radiation dose to patients from radiopharmaceuticals. Annals ICRP 1988;18
[10] Leblanc M, Tessier, M, Ollenberger, G, O’Brien, C. CANM Guidelines for Ventilation/Perfusion (V/P SPECT) in Pulmonary Embolism 2018. https://canm-acmn.ca/resources/Documents/Guidelines_Resources/MasterDocument_Final_Nov_21_incl-Exec-Sum_ver3_Dec.%2012_.pdf.
[11] Munkholm ML, Mortensen J. Mucociliary Clearance. Pathophysiological aspects. Clin Physiol Funct Imaging. 2014; 34(3): 171-7. doi: 10.1111/cpf.12085
[12] Marthin JK, Nielsen KG, Mortensen J. Quantitative 99mTc-albumin colloid nasal mucociliary clearance as an outcome in primary ciliary dyskinesia. ERJ Open Res. 2023 Sep 11;9(5):00345-2023. doi: 10.1183/23120541.00345-2023. PMID: 37701364; PMCID: PMC10493710.
[13] Munkholm M, Nielsen KG, Mortensen J. Clinical value of measurement of pulmonary radioaerosol mucociliary clearance in the work up of primary ciliary dyskinesia. EJNMMI Res. 2015 Dec;5(1):118. doi: 10.1186/s13550-015-0118-y. Epub 2015 Jul 16. PMID: 26179226; PMCID: PMC4503709.
[14] Marthin JK, Holgersen MG, Nielsen KG, Mortensen J. Pulmonary radioaerosol mucociliary clearance assessment: searching for genotype-specific differences and potential as an outcome measure in primary ciliary dyskinesia. ERJ Open Res. 2023 Dec 4;9(6):00685-2023. doi: 10.1183/23120541.00685-2023. PMID: 38076675; PMCID: PMC10702481.
[15] International Commission on Radiological Protection. Radiological Protection in Biomedical Research. Annals of the ICRP [Internet]. 1992;22(3). Available from: https://www.icrp.org/publication.asp?id=ICRP+Publication+62